Got my first infusion today.
Hope this finally gets the inflammation under control and reduces the pain in a few days... 🤞
seen from France
seen from United Kingdom
seen from United States
seen from United States
seen from United States

seen from Australia
seen from United States

seen from United States
seen from United States

seen from Australia

seen from United States
seen from United States

seen from Maldives
seen from Finland
seen from Serbia

seen from United States
seen from China

seen from United States
seen from Russia
seen from United States
Got my first infusion today.
Hope this finally gets the inflammation under control and reduces the pain in a few days... 🤞
looking up "crying after subcutaneous injection" because I just did mine and yeah it can give me brain fog but right now I'm overwhelmed and just want to cry for no reason??
anyway all the results are about pets injection so. no luck
I finally have an appointment with a dermatologist!!
I need to have a yearly checkup because the medication that keeps my chronic illness puts me at an increased risk for skin cancer (boo). But the skin doctor that I was seeing IN THE SAME HOSPITAL as my specialist ghosted me, won't answer my gastroenterologist or my GP...
So I called every single dermatologist in the area until I found one that accepted new patients and I finally got an appointment for May. 🥲
Yes I cried during those phonecalls but I'm counting this as a win!
Does anyone have tips for remembering injection sites? Like some kind of tracker or something?
I have to use two pens every two weeks and often struggle remembering where I injected last time. Thighs don't work well with me so I have to switch injection sites on my stomach which makes it harder to keep it varied... I'd really appreciate some advice!
Remsima (remicade) again at the hospital (2-9-2015)
Remsima (remicade) again at the hospital (2-9-2015)
[ad_1]
Remsima (remicade) again at the hospital (2-9-2015)
[ad_2]
View On WordPress
Celltrion files Remsima in the United States
Celltrion files Remsima in the United States
Celltrion files Remsima in the United States:
Celltrion announced that the company, on August 8, 2014, completed the filing procedure to obtain US FDA approval for its infliximab biosimilar. This marks the first 351(k) biosimilar mAb application to be filed in the U.S.A. and the second application for a biosimilar to be filed through the US BPCIA.
READ MORE
http://www.biosimilarnews.com/celltr…
View On WordPress